February 5, 2025

Plus, news about Au­ron Ther­a­peu­tics, Akribion Ther­a­peu­tics, En­ver­ic Bio­sciences and Va­le­rio Ther­a­peu­tics: Turn­stone Bi­o­log­ics to dis­con­tin­ue TIL stud­ies, “re­view strate­gic al­ter­na­tives”: The com­pa­ny Sign up

At long last, the FDA ap­proved Su­per­nus Phar­ma­ceu­ti­cals’ Parkin­son’s dis­ease treat­ment, which will be mar­ket­ed as On­ap­go. On­ap­go is now ap­proved … Sign up to

Bi­cy­cle Health, a provider of tele­health treat­ment for opi­oid use dis­or­der, has hit a ma­jor mile­stone that’s elud­ed many health tech star­tups: It turned a

Alzheimer’s dis­ease has af­flict­ed Han­nah Richard­son’s fam­i­ly for gen­er­a­tions. A rare ge­net­ic mu­ta­tion, passed down from her great-grand­moth­er, has struck her rel­a­tives with the first

Pfiz­er’s high-pro­file, high-volatil­i­ty Covid-19 fran­chise sta­bi­lized at the end of 2024, as the New York drug­mak­er pur­sues a re­vamp of its R&D op­er­a­tions and con­tin­ues

Re­gen­eron Phar­ma­ceu­ti­cals, one of the orig­i­nal and longest-stand­ing biotech com­pa­nies, is en­ter­ing the div­i­dends are­na for the first time. The Tar­ry­town, NY-based drug­mak­er sur­prised the

Physicians have launched a legal challenge against the Office of Personnel Management (OPM) and federal health agencies for removing webpages from health-related websites. Doctors for